X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (709) 709
Publication (98) 98
Patent (89) 89
Book Review (68) 68
Book Chapter (15) 15
Conference Proceeding (12) 12
Reference (2) 2
Book / eBook (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (466) 466
humans (448) 448
animals (215) 215
oncology (184) 184
melanoma (180) 180
melanoma - pathology (159) 159
mice (156) 156
cell biology (146) 146
cancer (119) 119
biochemistry (105) 105
melanoma - genetics (98) 98
cell line, tumor (97) 97
melanoma - metabolism (97) 97
article (95) 95
expression (92) 92
chemistry (85) 85
metallurgy (82) 82
beer (75) 75
enzymology (75) 75
microbiology (75) 75
mutation or genetic engineering (75) 75
spirits (75) 75
vinegar (75) 75
wine (75) 75
culture media (73) 73
human necessities (73) 73
hygiene (72) 72
medical or veterinary science (72) 72
preparations for medical, dental, or toilet purposes (72) 72
female (70) 70
dermatology (69) 69
compositions thereof (66) 66
microorganisms or enzymes (66) 66
propagating, preserving or maintaining microorganisms (66) 66
tumor cells, cultured (66) 66
skin neoplasms - pathology (58) 58
peptides (55) 55
organic chemistry (54) 54
cell line (53) 53
malignant-melanoma (51) 51
cells (48) 48
cells, cultured (48) 48
investigating or analysing materials by determining theirchemical or physical properties (48) 48
measuring (48) 48
physics (48) 48
testing (48) 48
signal transduction (46) 46
apoptosis (44) 44
antibodies, monoclonal (43) 43
biochemistry & molecular biology (43) 43
melanoma - immunology (43) 43
tumors (43) 43
male (42) 42
disease progression (41) 41
melanoma - drug therapy (41) 41
gene expression (38) 38
proteins (38) 38
growth (37) 37
metastasis (37) 37
molecular biology (37) 37
mice, scid (36) 36
abridged index medicus (35) 35
mutation (35) 35
gene (34) 34
tumor progression (34) 34
melanocytes - metabolism (33) 33
metastatic melanoma (33) 33
braf (32) 32
proto-oncogene proteins b-raf - genetics (32) 32
medicine, research & experimental (31) 31
mice, nude (31) 31
resistance (31) 31
differentiation (30) 30
gene expression regulation, neoplastic (30) 30
cell lines (29) 29
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (29) 29
multidisciplinary sciences (29) 29
neoplasm invasiveness (29) 29
phenotype (29) 29
progression (29) 29
research (29) 29
therapy (29) 29
antigens, neoplasm - analysis (28) 28
immunohistochemistry (28) 28
melanocytes (28) 28
melanoma - therapy (28) 28
skin neoplasms - genetics (28) 28
skin neoplasms - metabolism (27) 27
cell differentiation (26) 26
in-vitro (26) 26
models, biological (26) 26
neoplasm transplantation (26) 26
activation (25) 25
cell proliferation (25) 25
genetics & heredity (25) 25
in-vivo (25) 25
melanocytes - cytology (25) 25
transfection (25) 25
adult (24) 24
general tagging of cross-sectional technologies spanning over several sections of the ipc (24) 24
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Melanoma Management, ISSN 2045-0885, 09/2016, Volume 3, Issue 3, pp. 165 - 169
Dr Meenhard Herlyn is Caspar Wistar Professor for Melanoma Research and Director of the Melanoma Research Center at The Wistar Institute in Philadelphia, as... 
models | melanoma | therapy | monoclonal antibodies | Interview
Journal Article
1993, Medical intelligence unit., ISBN 9781879702554, vi, 102
Book
Pigment Cell & Melanoma Research, ISSN 1755-1471, 11/2016, Volume 29, Issue 6, pp. 605 - 606
Journal Article
Pigment Cell & Melanoma Research, ISSN 1755-1471, 03/2012, Volume 25, Issue 2, pp. 279 - 280
Journal Article
Journal Article
Nature, ISSN 0028-0836, 06/2017, Volume 546, Issue 7658, pp. 431 - 435
Therapies that target signalling molecules that are mutated in cancers can often have substantial short-term effects, but the emergence of resistant cancer... 
METASTATIC MELANOMA | BRAF INHIBITOR | SUBPOPULATIONS | CHROMATIN | MULTIDISCIPLINARY SCIENCES | SINGLE MAMMALIAN-CELLS | STATE | MECHANISMS | MUTATIONS | VEMURAFENIB | PLASTICITY | Transcription, Genetic - drug effects | Humans | Male | Transcription Factor AP-1 - metabolism | DNA-Binding Proteins - metabolism | Melanoma - genetics | Female | Indoles - pharmacology | Epigenesis, Genetic - drug effects | Gene Expression Regulation, Neoplastic - drug effects | SOXE Transcription Factors - deficiency | Single-Cell Analysis | Cellular Reprogramming - genetics | ErbB Receptors - metabolism | In Situ Hybridization, Fluorescence | Nuclear Proteins - metabolism | Signal Transduction - genetics | Melanoma - pathology | Sulfonamides - pharmacology | Cellular Reprogramming - drug effects | Transcription Factors - metabolism | Xenograft Model Antitumor Assays | Genetic Markers - drug effects | Vemurafenib | Drug Resistance, Neoplasm - genetics | Animals | Signal Transduction - drug effects | Genetic Markers - genetics | Cell Line, Tumor | Oncogene Protein p65(gag-jun) - metabolism | Drug Resistance, Neoplasm - drug effects | SOXE Transcription Factors - genetics | Antimitotic agents | Cell interaction | Dosage and administration | Antineoplastic agents | Drug resistance | Observations | Health aspects | Subpopulations | Transcription factors | Substance abuse treatment | Variability | Activator protein 1 | Melanoma | Genomes | Kinases | Gene expression | Sox10 protein | Signal transduction | Signaling | Converting | Population | Mutation | Differentiation | Deoxyribonucleic acid--DNA | Cancer | Index Medicus
Journal Article
Journal of Investigative Dermatology, ISSN 0022-202X, 02/2015, Volume 135, Issue 2, pp. 337 - 338
Activating mutations in have been identified in melanomas of acral and mucosal types and in those arising in chronically sun-damaged skin. Until now, KIT has... 
PHASE-II TRIAL | MUCOSAL MELANOMA | EXPRESSION | IMATINIB MESYLATE | COMPLETE RESPONSE | DERMATOLOGY | Proto-Oncogene Proteins c-kit - genetics | Melanoma - genetics | Epigenesis, Genetic | Humans | Skin Neoplasms - genetics | Index Medicus
Journal Article
细胞研究:英文版, ISSN 1001-0602, 2014, Issue 8, pp. 906 - 907
Slow-cycling BRAF^V600E melanoma cells are notoriously resistant to standard chemotherapy or targeted therapy but the underlying mechanism remains elusive. Now... 
黑色素细胞 | 靶向治疗 | 抵抗力 | 自行车
Journal Article
Nature Medicine, ISSN 1078-8956, 06/2012, Volume 18, Issue 6, pp. 853 - 854
Journal Article
Pigment Cell & Melanoma Research, ISSN 1755-1471, 12/2010, Volume 23, Issue 6, pp. 834 - 834
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 03/2014, Volume 124, Issue 3, pp. 1406 - 1417
Journal Article
Nature, ISSN 0028-0836, 08/2018, Volume 560, Issue 7718, pp. 382 - 386
Tumour cells evade immune surveillance by upregulating the surface expression of programmed death-ligand 1 (PD-L1), which interacts with programmed death-1... 
CELLS | MELANOMA | PEMBROLIZUMAB | EXTRACELLULAR VESICLES | MULTIDISCIPLINARY SCIENCES | RESISTANCE | INDUCE APOPTOSIS | EXPRESSION | T-LYMPHOCYTES | NECK-CANCER | CHECKPOINT BLOCKADE | Exosomes - metabolism | Tumor Escape - drug effects | Prognosis | Humans | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Case-Control Studies | Neoplasm Metastasis | Immune Tolerance - immunology | Antibodies, Monoclonal, Humanized - pharmacology | Female | Immune Tolerance - drug effects | Tumor Escape - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Melanoma - pathology | B7-H1 Antigen - immunology | Disease Progression | Antineoplastic Agents, Immunological - pharmacology | Xenograft Model Antitumor Assays | B7-H1 Antigen - metabolism | Animals | B7-H1 Antigen - blood | Antineoplastic Agents, Immunological - therapeutic use | Melanoma - immunology | Mice, Nude | CD8-Positive T-Lymphocytes - drug effects | Interferon-gamma - immunology | Melanoma - drug therapy | Cell Line, Tumor | Mice | Programmed Cell Death 1 Receptor - immunology | CD8-Positive T-Lymphocytes - immunology | Interferon-gamma - blood | Viral antibodies | Immunosuppression | Antibodies | Metastasis | Research | T cells | Properties | Biological response modifiers | Therapy | PD-1 protein | CD8 antigen | Lymphocytes T | Exosomes | Cancer therapies | Metastases | Skin cancer | Proteins | Vesicles | Lymphocytes | Immunotherapy | Immune system | Immunoglobulins | Melanoma | Immunosurveillance | T cell receptors | Patients | Immune checkpoint | Microscopy | PD-L1 protein | Ligands | Interferon | Head & neck cancer | Tumors | Apoptosis | Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2017, Volume 23, Issue 12, pp. 3097 - 3108
Purpose: PARP inhibition (PARPi) has modest clinical activity in recurrent BRCA-mutant (BRCA(MUT)) high-grade serous ovarian cancers (HGSOC). We hypothesized... 
OLAPARIB | THERAPY | RANDOMIZED PHASE-2 | CHK1 | ONCOLOGY | PHOSPHORYLATION | SYNTHETIC LETHALITY | CELL-CYCLE | CHECKPOINT | REPLICATION FORK COLLAPSE | ATR | Piperazines - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Phthalazines - administration & dosage | Pyrimidines - administration & dosage | Humans | Checkpoint Kinase 1 - antagonists & inhibitors | Ovarian Neoplasms - pathology | Molecular Targeted Therapy | Poly(ADP-ribose) Polymerase Inhibitors - administration & dosage | Drug Synergism | Ovarian Neoplasms - genetics | Xenograft Model Antitumor Assays | BRCA1 Protein - genetics | Sulfoxides - administration & dosage | Pyrazoles - administration & dosage | Animals | Ataxia Telangiectasia Mutated Proteins - antagonists & inhibitors | Cell Line, Tumor | Genomic Instability - drug effects | Female | Cell Proliferation - drug effects | Mice | Ovarian Neoplasms - drug therapy | Ovarian carcinoma | G2 phase | Genomes | Ovarian cancer | Genomic instability | Quality | Cell cycle | Xenografts | Remission | Inhibition | Cell survival | Stability | BRCA1 protein | Colonies | CHK1 protein | Regression | Poly(ADP-ribose) polymerase | Breast cancer | Stability analysis | Regression analysis | Survival | Experimental design | Cell death | Aberration | Chromosome aberrations | Cancer | Apoptosis | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 11/2012, Volume 491, Issue 7424, pp. 342 - 343
Caucasians are generally at a higher risk of developing melanoma than are non-Caucasians, and red-haired individuals in particular are more susceptible to... 
Mutation | Sunscreen | Genes | Skin cancer
Journal Article
Journal of visualized experiments : JoVE, ISSN 1940-087X, 05/2019, Issue 147
Accumulating evidence suggests that molecular and biological properties differ in melanoma cells grown in traditional two-dimensional tissue culture vessels... 
Journal Article
Pigment Cell & Melanoma Research, ISSN 1755-1471, 11/2012, Volume 25, Issue 6, pp. 832 - 833
Journal Article
Cancer Research, ISSN 0008-5472, 04/2011, Volume 71, Issue 8 Supplement, pp. 1244 - 1244
Journal Article
Pigment Cell & Melanoma Research, ISSN 1755-1471, 03/2012, Volume 25, Issue 2, pp. 279 - 280
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.